CannaPharmaRX, Inc.
CPMD
$0.00
$0.00-4.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.65M | 1.36M | 1.71M | 1.36M | 1.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.65M | 1.36M | 1.71M | 1.36M | 1.13M |
| Cost of Revenue | 4.03M | 3.69M | 5.19M | 4.53M | 3.85M |
| Gross Profit | -2.37M | -2.33M | -3.49M | -3.17M | -2.72M |
| SG&A Expenses | 926.00K | 959.30K | 524.80K | 423.20K | 541.20K |
| Depreciation & Amortization | -- | -- | -87.30K | -87.30K | -23.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.95M | 4.65M | 5.63M | 4.87M | 4.37M |
| Operating Income | -3.30M | -3.29M | -3.93M | -3.51M | -3.24M |
| Income Before Tax | -10.82M | -11.13M | -7.32M | -5.66M | 1.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.82 | -11.13 | -7.32 | -5.66 | 1.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.82M | -11.13M | -7.32M | -5.66M | 1.12M |
| EBIT | -3.30M | -3.29M | -3.93M | -3.51M | -3.24M |
| EBITDA | -1.47M | -1.46M | -2.99M | -3.51M | -3.18M |
| EPS Basic | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.66B | 2.65B | 2.65B | 2.65B | 2.65B |
| Average Diluted Shares Outstanding | 2.66B | 2.65B | 2.65B | 2.65B | 2.65B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |